title: Workgroup #2: Screening and detection. Reference range/clinical issues of PSA.
authors.affiliation: Roswell Park Cancer Institute, Epidemiology Research, Buffalo, NY 14263.
authors.forename: C J
authors.initials: CJ
authors.lastname: Mettlin
authors.forename: B
authors.initials: B
authors.lastname: Black
authors.forename: F
authors.initials: F
authors.lastname: Lee
authors.forename: P J
authors.initials: PJ
authors.lastname: Littrup
authors.forename: A
authors.initials: A
authors.lastname: DuPont
authors.forename: R
authors.initials: R
authors.lastname: Babaian
mesh_terms: D003365:Costs and Cost Analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood*; D012016:Reference Values
chemical_list: D017430:Prostate-Specific Antigen